The ketogenic diet: Scientific principles underlying its use

Epilepsy: Mechanisms, Models, and Translational Perspectives

Volumn , Issue , 2010, Pages 417-439

  Bough, Kristopher J ^a   Stafstrom, Carl E ^b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84864107955     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420085594     Document Type: Chapter

References (160)

1. Antozzi, C., S. Franceschetti, G. Filippini, B. Barbiroli, M. Savoiardo, F. Fiacchino, M. Rimoldi, R. Lodi, P. Zaniol, M. Zeviani. (1995). Epilepsia, partialis continua associated with NADH-coenzyme Q reductase deficiency. J. Neurol. Sci., 129:152-161.
2. Appleton, D.B., D.C. De Vivo. (1974). An animal model for the ketogenic diet. Epilepsia, 15:211-217.
3. Attwell, D., S.B. Laughlin. (2001). An energy budget for signaling in the grey matter of the brain. J. Cereb. Blood Flow Metab., 21:1133-1145.
4. Ballaban-Gil, K., C. Callahan, C. O’Dell, M. Pappo, S. Moshe, S. Shinnar. (1998). Complications of the ketogenic diet. Epilepsia, 39:744-748.
5. Barborka, C.J. (1930). Results of treatment by ketogenic diet in 100 cases. Arch. Neurol. Psychiatr., 23:904-914.
6. Berry-Kravis, E., G. Booth, A.C. Sanchez, J. Woodbury-Kolb. (2001a). Carnitine levels and the ketogenic diet. Epilepsia, 42:1445-1451.
7. Berry-Kravis, E., B. Booth, A. Taylor, L.A. Valentino. (2001b). Bruising and the ketogenic diet: evidence for diet-induced changes in platelet function. Ann. Neurol., 49:98-103.
8. Best, T.H., D.N. Franz, D.L. Gilbert, D.P. Nelson, M.R. Epstein. (2000). Cardiac complications in pediatric patients on the ketogenic diet. Neurology, 54:2328-2330.
9. Boles, R.G., M.R. Seashore, W.G. Mitchell, P.R. Kollros, S. Mofidi, E.J. Novotny. (1999). Glucose transporter type 1 deficiency: a study of two cases with video-EEG. Eur. J. Pediatr., 158:978-983.
10. Bough, K.J., D.A. Eagles. (1999). A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia, 40:138-143.
11. Bough, K.J., D.A. Eagles. (2001). Comparison of the anticonvulsant efficacies and neurotoxic effects of valproic acid, phenytoin, and the ketogenic diet. Epilepsia, 42:1345-1353.
12. Bough, K.J., J.M. Rho. (2007). Anticonvulsant mechanisms of the ketogenic diet. Epilepsia, 48:43-58.
13. Bough, K.J., R. Chen, D.A. Eagles. (1999a). Path analysis shows that increasing ketogenic ratio, but not betahydroxybutyrate, elevates seizure threshold in the rat. Dev. Neurosci., 21:400-406.
14. Bough, K.J., R. Valiyil, F.T. Han, D.A. Eagles. (1999b). Seizure resistance is dependent upon age and caloric restriction in rats fed a ketogenic diet. Epilepsy Res., 35:21-28.
15. Bough, K.J., P.J. Matthews, D.A. Eagles. (2000a). A ketogenic diet has different effects upon seizures induced by maximal electroshock and by pentylenetetrazole infusion. Epilepsy Res., 38:105-114.
16. Bough, K.J., S.G. Yao, D.A. Eagles. (2000b). Higher ketogenic diet ratios confer protection from seizures without neurotoxicity. Epilepsy Res., 38:15-25.
17. Bough, K.J., K. Gudi, F.T. Han, A.H. Rathod, D.A. Eagles. (2002). An anticonvulsant profile of the ketogenic diet. Epilepsy Res., 50:313-325.
18. Bough, K.J., P.A. Schwartzkroin, J.M. Rho. (2003). Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia, 44:752-760.
19. Bough, K.J., J. Wetherington, B. Hassel, J.F. Pare, J.W. Gawryluk, J.G. Greene, R. Shaw, Y. Smith, J.D. Geiger, R.J. Dingledine. (2006). Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol., 60:223-235.
20. Bromfield, E., B. Dworetzky, S. Hurwitz, Z. Eluri, L. Lane, S. Replansky, D. Mostofsky. (2008). A randomized clinical trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav., 12:187-190.
21. Cantello, R., C. Varrasi, R. Tarletti, M. Cecchin, F. D’Andrea, P. Veggiotti, G. Bellomo, F. Monaco. (2007). Ketogenic diet: electrophysiological effects on the normal human cortex. Epilepsia, 48:1756-1763.
22. Carroll, J., D. Koenigsberger. (1998). The ketogenic diet: a practical guide for caregivers. J. Am. Diet. Assoc., 98:316-321.
23. Coppola, G., P. Veggiotti, R. Cusmai, S. Bertoli, S. Cardinali, C. Dionisi-Vici, M. Elia, M.L. Lispi, C. Sarnelli, A. Tagliabue, C. Toraldo, A. Pascotto. (2002). The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an Italian multicentric experience. Epilepsy Res., 48:221-227.
24. Couch, S., F. Schwarzman, J. Carroll, D. Koenigsberger, D.R. Nordli, Jr., R.J. Deckelbaum, A.R. DeFelice. (1999). Growth and nutritional outcomes of children treated with the ketogenic diet. J. Am. Diet. Assoc., 99:1573-1575.
25. De Vivo, D.C., K.L. Malas, M.P. Leckie. (1975). Starvation and seizures. Arch. Neurol., 32:755-760.
26. De Vivo, D.C., M.P. Leckie, J.S. Ferrendelli, D.B. McDougal. (1978). Chronic ketosis and cerebral metabolism. Ann. Neurol., 3:331-337.
27. De Vivo, D.C., R.R. Trifiletti, R.I. Jacobson, G.M. Ronen, R.A. Behmand, S.I. Harik. (1991). Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N. Engl. J. Med., 325:703-709.
28. De Vivo, D.C., T.P. Bohan, D.L. Coulter, F.E. Dreifuss, R.S. Greenwood, D.R. Nordli, Jr., W.D. Shields, C.E. Stafstrom, I. Tein. (1998). l-Carnitine supplementation in childhood epilepsy: current perspectives. Epilepsia, 39:1216-1225.
29. Dekaban, A.S. (1966). Plasma lipids in epileptic children treated with the high fat diet. Arch. Neurol., 15:177-184.
30. Dell, C.A., S.S. Likhodii, K. Musa, M.A. Ryan, W.M. Burnham, S.C. Cunnane. (2001). Lipid and fatty acid profiles in rats consuming different high-fat ketogenic diets. Lipids 36:373-378.
31. Dodson, W.E., A.L. Prensky, D.C. De Vivo, S. Goldring, P.R. Dodge. (1976). Management of seizure disorders:selected aspects, Part II. J. Pediatr., 89:695-703.
32. Donevan, S.D., H.S. White, G.D. Anderson, J.M. Rho. (2003). Voltage-dependent block of N-methyl-daspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of l-(+)-betahydroxybutyrate. Epilepsia, 44:1274-1279.
33. Ducray, A.D., R. Qualls, U. Schlattner, R.H. Andres, E. Dreher, R.W. Seiler, T. Wallimann, H.R. Widmer. (2007). Creatine promotes the GABAergic phenotype in human fetal spinal cord cultures. Brain Res., 1137:50-57.
34. Erecinska, M., D. Nelson, Y. Daikhin, M. Yudkoff. (1996). Regulation of GABA level in rat brain synaptosomes:fluxes through enzymes of the GABA shunt and effects of glutamate, calcium, and ketone bodies. J. Neurochem., 67:2325-2334.
35. Fraser, D.D., S. Whiting, R.D. Andrew, E.A. Macdonald, K. Musa-Veloso, S.C. Cunnane. (2003). Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet. Neurology, 60:1026-1029.
36. Freeman, J.M. (2001). The ketogenic diet and epilepsy. Nestle Nutr. Workshop Ser. Clin. Perf. Prog., 5:307-321.
37. Freeman, J.M., E. Vining, D. Pillas, P. Pyzik, J. Casey, M. Kelly. (1998). The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics, 102:1358-1363.
38. Freeman, J.M., E.H. Kossoff, J.B. Freeman, M.T. Kelly. (2007a). The Ketogenic Diet-A Treatment for Children and Others with Epilepsy, 4th ed. New York: Demos Publications.
39. Freeman, J.M., E.H. Kossoff, A.L. Hartman. (2007b). The ketogenic diet: one decade later. Pediatrics, 119:535-543.
40. Freeman, J.M., E.P.G. Vining, E.H. Kossoff, P.L. Pyzik, X. Ye, S.N. Goodman. (2009). A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia, 50(2):322-325.
41. Furth, S.L., J.C. Casey, P.L. Pyzik, A.M. Neu, S.G. Docimo, E.P. Vining, J.M. Freeman, B.A. Fivush. (2000). Risk factors for urolithiasis in children on the ketogenic diet. Pediatr. Nephrol., 15:125-128.
42. Garriga-Canut, M., B. Schoenike, R. Quazi, K. Bergendahl, T.J. Daley, R.M. Pfender, J.F. Morrison, J. Ockuly, C. Stafstrom, T. Sutula, A. Roopra. (2006). 2-Deoxy-d-glucose reduces epilepsy progression by NRSFCtBP- dependent metabolic regulation of chromatin structure. Nat. Neurosci., 9:1382-1387.
43. Gasior, M., M.A. Rogawski, A.L. Hartman. (2006). Neuroprotective and disease-modifying effects of the ketogenic diet. Behav. Pharmacol., 17:431-439.
44. Gasior, M., A. French, M.T. Joy, R.S. Tang, A.L. Hartman, M.A. Rogawski. (2007). The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolite acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia, 48:793-800.
45. Geyelin, H. (1921). Fasting as a method for treating epilepsy. Med. Rec., 99:1037-1039.
46. Gilbert, D.L., P.L. Pyzik, J.M. Freeman. (2000). The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones. J. Child Neurol., 15:787-790.
47. Greene, A.E., M.T. Todorova, R. McGowan, T.N. Seyfried. (2001). Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia, 42:1371-1378.
48. Hartman, A.L., M. Gasior, E.P. Vining, M.A. Rogawski. (2007). The neuropharmacology of the ketogenic diet. Pediatr. Neurol., 36:281-292.
49. Hartman, A.L., M. Lyle, M.A. Rogawski, M. Gasior. (2008). Efficacy of the ketogenic diet in the 6-Hz seizure test. Epilepsia, 49:334-339.
50. He, X.P., R. Kotloski, S. Nef, B.W. Luikart, L.F. Parada, J.O. McNamara. (2004). Conditional deletion of TrkB but not BDNF prevents epileptogenesis in the kindling model. Neuron, 43:31-42.
51. Helmholz, H.F., H.M. Keith. (1930). Eight years’ experience with the ketogenic diet in the treatment of epilepsy. JAMA, 95:707-709.
52. Hemingway, C., J.M. Freeman, D.J. Pillas, P.L. Pyzik. (2001). The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics, 108:898-905.
53. Henderson, C.B., F.M. Filloux, S.C. Alder, J.L. Lyon, D.A. Caplin. (2006). Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J. Child Neurol., 21:193-198.
54. Henry, T.R., J.R. Votaw. (2004). The role of positron emission tomography with [18F]-fluorodeoxyglucose in the evaluation of the epilepsies. Neuroimaging Clin. N. Am., 14:517-535.
55. Herzberg, G.Z., B.A. Fivush, S.L. Kinsman, J.P. Gearhart. (1990). Urolithiasis associated with the ketogenic diet. J. Pediatr., 117:742-745.
56. Holmes, G.L., Q. Zhao. (2008). Choosing the correct antiepileptic drugs: from animal studies to the clinic. Pediatr. Neurol., 38:151-162.
57. Hori, A., P. Tandon, G.L. Holmes, C.E. Stafstrom. (1997). Ketogenic diet: effects on expression of kindled seizures and behavior in adult rats. Epilepsia, 38:750-758.
58. Huttenlocher, P.R. (1976). Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr. Res., 10:536-540.
59. Huttenlocher, P.R., A.J. Wilbourn, J.M. Signore. (1971). Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology, 21:1097-1103.
60. Iadarola, M.J., K. Gale. (1982). Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science, 218:1237-1240.
61. Janigro, D. (1999). Blood-brain barrier, ion homeostasis and epilepsy: possible implications towards the understanding of ketogenic diet mechanisms. Epilepsy Res., 37:223-232.
62. Kang, H.C., D.E. Chung, D.W. Kim, H.D. Kim. (2004). Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia, 45:1116-1123.
63. Kang, H.C., H.S. Lee, S.J. You, D.C. Kang, T.S. Ko, H.D. Kim. (2007). Use of a modified Atkins diet in intractable childhood epilepsy. Epilepsia, 48:182-186.
64. Kaytal, N.G., A.N. Koehler, B. McGhee, C.M. Foley, P.K. Crumrine. (2000). The ketogenic diet in refractory epilepsy: the experience of Children’s Hospital of Pittsburgh. Clin. Pediatr., 39:153-159.
65. Keene, D.L. (2006). A systematic review of the use of the ketogenic diet in childhood epilepsy. Pediatr. Neurol. 35:1-5.
66. Kim, D.Y., J.M. Rho. (2008). The ketogenic diet and epilepsy. Curr. Opin. Clin. Nutr. Metab. Care 11:113-120.
67. Kinsman, S.L., E.P.G. Vining, S.A. Quaskey, D. Mellits, J.M. Freeman. (1992). Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia, 33:1132-1136.
68. Kossoff, E.H., J.R. McGrogan. (2005). Worldwide use of the ketogenic diet. Epilepsia, 46:280-289.
69. Kossoff, E.H., G.L. Krauss, J.R. McGrogan, J.M. Freeman. (2003). Efficacy of the Atkins diet as therapy for intractable epilepsy. Neurology, 61:1789-1791.
70. Kossoff, E.H., J.R. McGrogan, R.M. Bluml, D.J. Pillas, J.E. Rubenstein, E.P. Vining. (2006). A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia, 47:421-424.
71. Kossoff, E.H., Z. Turner, R., M. Bluml, P.L. Pyzik, E.P. Vining. (2007). A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav., 10:432-436.
72. Kossoff, E.H., L.C. Laux, R. Blackford, P.F. Morrison, P.L. Pyzik, R.M. Hamdy, Z. Turner, D.R. Nordli, Jr. (2008a). When do seizures usually improve with the ketogenic diet? Epilepsia, 49:329-333.
73. Kossoff, E.H., H. Rowley, S.R. Sinha, E.P. Vining. (2008b). A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia, 49:316-319.
74. Kossoff, E.H., B.A. Zupec-Kania, P.E. Amark, K.R. Ballaban-Gil, A.G. Christina Bergqvist, R. Blackford et al. (2009). Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Study Group. Epilepsia, 50(2):304-317.
75. Kudin, A.P., T.A. Kudina, J. Seyfried, S. Vielhaber, H. Beck, C.E. Elger, W.S. Kunz. (2002). Seizuredependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus. Eur. J. Neurosci., 15:1105-1114.
76. Kunz, W.S., A.P. Kudin, S. Vielhaber, I. Blumcke, W. Zuschratter, J. Schramm, H. Beck, C.E. Elger. (2000). Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann. Neurol., 48:766-773.
77. Kwon, Y.S., S.W. Jeong, D.W. Kim, E.S. Choi, B.K. Son. (2008). Effects of the ketogenic diet on neurogenesis after kainic acid-induced seizures in mice. Epilepsy Res., 78:186-194.
78. Leaf, A., J. Kang, Y.F. Xiao, G. Billman, R. Voskuyl. (1999). Functional and electrophysiologic effects of polyunsaturated fatty acids on excitable tissues: heart and brain. Prostagland. Leukotr. Essen. Fatty Acids, 60:307-312.
79. Lefevre, F., N. Aronson. (2000). Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics, 105(4):E46.
80. Lian, X.Y., F.A. Khan, J.L. Stringer. (2007). Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats. J. Neurosci., 27:12007-12011.
81. Likhodii, S.S., K. Musa, A. Mendonca, C. Dell, W.M. Burnham, S.C. Cunnane. (2000). Dietary fat, ketosis, and seizure resistance in rats on the ketogenic diet. Epilepsia, 41:1400-1410.
82. Likhodii, S.S., K. Musa, S.C. Cunnane. (2002). Breath acetone as a measure of systemic ketosis assessed in a rat model of the ketogenic diet. Clin. Chem., 48:115-120.
83. Likhodii, S.S., I. Serbanescu, M.A. Cortez, P. Murphy, O.C. Snead, 3rd, W.M. Burnham. (2003). Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann. Neurol., 54:219-226.
84. Livingston, S. (1972). Dietary treatment of epilepsy. In Comprehensive Management of Epilepsy in Infancy, Childhood and Adolescence (pp. 378-405), S. Livingston, Ed. Springfield, IL: Charles C Thomas.
85. Ludwig, D.S. (2007). Clinical update: the low-glycaemic-index diet. Lancet, 369: 890-892.
86. Ma, W., J. Berg, G. Yellen. (2007). Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J. Neurosci., 27:3618-3625.
87. Maalouf, M., J.M. Rho. (2008). Oxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies. J. Neurosci. Res., 86: 3322-3330.
88. Maalouf, M., P.G. Sullivan, L. Davis, D.Y. Kim, J.M. Rho. (2007). Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience, 145:256-264.
89. Magrath, G., A. MacDonald, W. Whitehouse. (2000). Dietary practices and use of the ketogenic diet in the UK. Seizure, 9:128-130.
90. Mantis, J.G., N.A. Centeno, M.T. Todorova, R. McGowan, T.N. Seyfried. (2004). Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr. Metab., 1:1-11.
91. Maydell, B.V., E. Wyllie, N. Akhtar, P. Kotagal, K. Powaski, K. Cook, A. Weinstock, A.D. Rothner. (2001). Efficacy of the ketogenic diet in focal versus generalized seizures. Pediatr. Neurol., 25:208-212.
92. McGarry, J.D., D.W. Foster. (1980). Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem., 49:395-420.
93. Melo, T.M., A. Nehlig, U. Sonnewald. (2006). Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem. Int., 48:498-507.
94. Millichap, J.G., J.D. Jones, B.P. Rudis. (1964). Mechanism of anticonvulsant action of the ketogenic diet. Am. J. Dis. Child, 107:593-604.
95. Muller-Schwarze, A.B., P. Tandon, Z. Liu, Y. Yang, G.L. Holmes, C.E. Stafstrom. (1999). Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. NeuroReport, 10:1517-1522.
96. Murphy, P., W.M. Burnham. (2006). The ketogenic diet causes a reversible decrease in activity level in Long-Evans rats. Exp. Neurol., 201:84-99.
97. Nakazawa, M., S. Kodama, T. Matsuo. (1983). Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides. Brain Dev., 5:375-380.
98. Neal, E.G., H. Chaffe, R.H. Schwartz, M.S. Lawson, N. Edwards, G. Fitzsimmons, A. Whitney, J.H. Cross. (2008). The ketogenic diet for the treatment of childhood epilepsy: a randomized controlled trial. Lancet Neurol., 7:500-506.
99. Noh, H.S., Y.S. Kim, H.P. Lee, K.M. Chung, D.W. Kim, S.S. Kang, G.J. Cho, W.S. Choi. (2003). The protective effect of a ketogenic diet on kainic acid-induced hippocampal cell death in the male ICR mice. Epilepsy Res., 53:119-128.
100. Noh, H.S., H.P. Lee, D.W. Kim, S.S. Kang, G.J. Cho, J.M. Rho, W.S. Choi. (2004). A cDNA microarray analysis of gene expression profiles in rat hippocampus following a ketogenic diet. Molec. Brain Res., 129:80-87.
101. Noh, H.S., D.W. Kim, G.J. Cho, W.S. Choi, S.S. Kang. (2006). Increased nitric oxide caused by the ketogenic diet reduces the onset time of kainic acid-induced seizures in ICR mice. Brain Res., 1075:193-200.
102. Nordli, Jr., D.R., D.C. De Vivo. (1997). The ketogenic diet revisited: back to the future. Epilepsia, 38:743-749.
103. Nordli, Jr., D.R., M.M. Kuroda, J. Carroll, D.Y. Koenigsberger, L.J. Hirsch, H.J. Bruner, W.T. Seidel, D.C. De Vivo. (2001). Experience with the ketogenic diet in infants. Pediatrics, 108:129-133.
104. Nylen, K., J.L. Velazquez, S.S. Likhodii, M.A. Cortez, L. Shen, Y. Leshchenko, K. Adeli, K.M. Gibson, W.M. Burnham, O.C. Snead, 3rd. (2008). A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotype. Exp. Neurol., 210:449-457.
105. Otani, K., A. Yamatodani, H. Wada, T. Mimaki, H. Yabuuchi. (1984). Effect of ketogenic diet on convulsive threshold and brain monoamine levels in young mice. No To Hattatsu, 16:196-204.
106. Pan, J.W., E. Bebin, W. Chu, H.P. Hetherington. (1999). Ketosis and epilepsy: 31P spectroscopic imaging at 4.1 T. Epilepsia, 40:703-707.
107. Pan, J.W., D.L. Rothman, K.L. Behar, D.T. Stein, H.P. Hetherington. (2000). Human brain beta-hydroxybutyrate and lactate increase in fasting-induced ketosis. J. Cereb. Blood Flow Metab., 20:1502-1507.
108. Pan, J.W., I. Cavus, J. Kim, H.P. Hetherington, D.D. Spencer. (2008). Hippocampal extracellular GABA correlates with metabolism in human epilepsy. Metab. Brain. Dis., 23:457-468.
109. Pellerin, L., G. Pellegri, J.L. Martin, P.J. Magistretti. (1998). Expression of monocarboxylate transporter mRNAs in mouse brain: support for a distinct role of lactate as an energy substrate for the neonatal vs. adult brain. Proc. Nat. Acad. Sci. U.S.A., 95:3990-3995.
110. Peterman, M.G. (1925). The ketogenic diet in epilepsy. JAMA, 84:1979-1983.
111. Pfeifer, H.H., E.A. Thiele. (2005). Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology, 65:1810-1812.
112. Pulsifer, M., J. Gordon, E. Vining, J. Freeman. (2001). Effects of the ketogenic diet on development and behavior:preliminary report of a prospective study. Dev. Med. Child Neurol. 43:301-306.
113. Raffo, E., J. Francois, A. Ferrandon, E. Koning, A. Nehlig. (2008). Calorie-restricted ketogenic diet increases thresholds to all patterns of pentylenetetrazole-induced seizures: critical importance of electroclinical assessment. Epilepsia, 49:320-328.
114. Rauchenzauner, M., J. Klepper, B. Leiendecker, G. Luef, K. Rostasy, C. Ebenbichler. (2008). The ketogenic diet in children with GLUT1 deficiency syndrome and epilepsy. J. Pediatr., 153:716-718.
115. Rho, J.M., D. Kim, C. Robbins, G.D. Anderson, P. Schwartzkroin. (1999a). Age-dependent differences in flurothyl seizure sensitivity in mice treated with a ketogenic diet. Epilepsy Res., 37:233-240.
116. Rho, J.M., P. Szot, B.L. Tempel, P.A. Schwartzkroin. (1999b). Developmental seizure susceptibility of Kv1.1 potassium channel knockout mice. Dev. Neurosci., 21:320-327.
117. Rho, J.M., G.D. Anderson, S.D. Donevan, H.S. White. (2002). Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia, 43:358-361.
118. Saudek, C.D., P. Felig. (1976). The metabolic events of starvation. Am. J. Med., 60:117-126.
119. Schlanger, S., M. Shinitzky, D. Yam. (2002). Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia, 43:101989.
120. Schwartz, R.M., J. Eaton, B.D. Bower, A. Aynsley-Green. (1989). Ketogenic diets in the treatment of epilepsy:short-term clinical effects. Dev. Med. Child Neurol., 31:145-151.
121. Schwartzkroin, P. (1999). Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Res., 37:171-180.
122. Seymour, K.J., S. Bluml, J. Sutherling, W. Sutherling, B.D. Ross. (1999). Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet. MAGMA, 8:33-42.
123. Sills, M.A., W.I. Forsythe, D. Haidukewych, A. MacDonald, M. Robinson. (1986). The medium chain triglyceride diet and intractable epilepsy. Arch. Dis. Child, 61:1168-1172.
124. Sirven, J., B. Whedon, D. Caplan, J. Liborace, D. Glosser, J. O’Dwyer, M.R. Sperling. (1999). The ketogenic diet for intractable epilepsy in adults: preliminary results. Epilepsia, 40:1721-1726.
125. Stafstrom, C.E. (1999). Animal models of the ketogenic diet: what have we learned, what can we learn? Epilepsy Res., 37:241-259.
126. Stafstrom, C.E. (2001). Effects of fatty acids and ketones on neuronal excitability: implications for epilepsy and its treatment. In Fatty Acids-Physiological and Behavioral Functions (pp. 273-290), D.I. Mostofsky, S. Yehuda, and N. Salem, Eds. Totowa, NJ: Humana Press.
127. Stafstrom, C.E. (2004). Dietary approaches to epilepsy treatment: old and new options on the menu. Epilepsy Curr., 4:215-222.
128. Stafstrom, C.E., S. Spencer. (2000). The ketogenic diet: a therapy in search of an explanation. Neurology, 54:282-283.
129. Stafstrom, C.E., J.C. Ockuly, L. Murphree, M.T. Valley, A. Roopra, T.P. Sutula. (2009). Anticonvulsant and antiepileptic action of 2-deoxy-d-glucose in epilepsy models. Ann. Neurol., 65:435-447.
130. Stewart, W.A., K. Gordon, P. Camfield. (2001). Acute pancreatitis causing death in a child on the ketogenic diet. J. Child Neurol., 16:682.
131. Strandberg, J., D. Kondziella, T. Thorlin, F. Asztely. (2008). Ketogenic diet does not disturb neurogenesis in the dentate gyrus in rats. NeuroReport, 19:1235-1237.
132. Su, S.W., M.R. Cilio, Y. Sogawa, D. Silveira, G.L. Holmes, C.E. Stafstrom. (2000). Timing of ketogenic diet initiation in an experimental epilepsy model. Dev. Brain Res., 125:131-138.
133. Sullivan, P.G., N.A. Rippy, K. Dorenbos, R.C. Concepcion, A.K. Agarwal, J.M. Rho. (2004). The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol., 55:576-580.
134. Swink, T.D., E.P.G. Vining, J.M. Freeman. (1997). The ketogenic diet. Adv. Pediatr., 44:297-329.
135. Szot, P., D. Weinshenker, J.M. Rho, T.W. Storey, P.A. Schwartzkroin. (2001). Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Dev. Brain Res., 129:211-214.
136. Taha, A.Y., B.M. Baghiu, R. Lui, K. Nylen, D.W. Ma, W.M. Burnham. (2006). Lack of benefit of linoleic and alpha-linolenic polyunsaturated fatty acids on seizure latency, duration, severity or incidence in rats. Epilepsy Res., 71:40-46.
137. Thavendiranathan, P., A. Mendonca, C. Dell, S.S. Likhodii, K. Musa, C. Iracleous, S.C. Cunnane, W.M. Burnham. (2000). The MCT ketogenic diet: effects on animal seizure models. Exp. Neurol., 161:696-703.
138. Thio, L.L., M. Wong, K.A. Yamada. (2000). Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology, 54:325-331.
139. Todorova, M.T., P. Tandon, R.A. Madore, C.E. Stafstrom, T.N. Seyfried. (2000). The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia, 41:933-940.
140. Trauner, D.A. (1985). Medium-chain triglyceride (MCT) diet in intractable seizure disorders. Neurology, 35:237-238.
141. Uauy, R., P. Peirano, D. Hoffman, P. Mena, D. Birch, E. Birch. (1996). Role of essential fatty acids in the function of the developing nervous system. Lipids, 31(Suppl.):S167-S176.
142. Uhlemann, E.R., A.H. Neims. (1972). Anticonvulsant properties of the ketogenic diet in mice. J. Pharm. Exp. Therap., 180:231-238.
143. Vaisleib, I.I., J.R. Buchhalter, M.L. Zupanc. (2004). Ketogenic diet: outpatient initiation, without fluid, or caloric restrictions. Pediatr. Neurol., 31:198-202.
144. Vining, E.P.G. (1999). Clinical efficacy of the ketogenic diet. Epilepsy Res., 37:181-190.
145. Vining, E.P.G., J.M. Freeman, K. Ballaban-Gil, C.S. Camfield, P.R. Camfield, G.L. Holmes, S. Shinnar, R. Shuman, E. Trevathan, J.W. Wheless. (1998). A multicenter study of the efficacy of the ketogenic diet. Arch. Neurol., 55:1433-1437.
146. Vreugdenhil, M., C. Bruehl, R.A. Voskuyl, J.X. Kang, A. Leaf, W.J. Wadman. (1996). Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc. Nat. Acad. Sci. U.S.A., 93:12559-12563.
147. Wexler, I.D., S.G. Hemalatha, J. McConnell, N.R. Buist, H.H. Dahl, S.A. Berry, S.D. Cederbaum, M.S. Patel, D.S. Kerr. (1997). Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Neurology, 49:1655-1661.
148. Wheless, J.W. (1995). The ketogenic diet: fa(c)t or fiction. J. Child Neurol., 10:419-423.
149. Wheless, J.W. (2001). The ketogenic diet: an effective medical therapy with side effects. J. Child Neurol., 16:633-635.
150. Wheless, J.W. (2004). History and origin of the ketogenic diet. In Epilepsy and the Ketogenic Diet (pp. 31-50), C.E. Stafstrom and J.M. Rho, Eds. Totowa, NJ: Humana Press.
151. Wijburg, F.A, P.G. Barth, L.A. Bindoff, M.A. Birch-Machin, J.F. van der Blij, W. Ruitenbeek, D.M. Turnbull, R.B. Schutgens. (1992). Leigh syndrome associated with a deficiency of the pyruvate dehydrogenase complex: results of treatment with a ketogenic diet. Neuropediatrics, 23:147-152.
152. Wilder, R.M. (1921). The effects of ketonemia on the course of epilepsy. Mayo Clin. Proc., 2:307-308.
153. Williamson, A., P.R. Patrylo, J. Pan, D.D. Spencer, H. Hetherington. (2005). Correlations between granule cell physiology and bioenergetics in human temporal lobe epilepsy. Brain, 128(Pt. 5):1199-1208.
154. Willis, S., R. Samala, T.A. Rosenberger, K. Borges. (2009). Eicosapentaenoic and docosahexaenoic acids are not anticonvulsant or neuroprotective in acute mouse seizure models. Epilepsia, 50:138-142.
155. Wing, R., J. Vazquez, C. Ryan. (1995). Cognitive effects of ketogenic weight-reducing diets. Int. J. Obesity, 19:811-816.
156. Xiao, Y.-F., X. Li. (1999). Polyunsaturated fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res., 846:112-121.
157. Yudkoff, M., Y. Daikhin, T.M. Melo, I. Nissim, U. Sonnewald, I. Nissim. (2007). The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annu. Rev. Nutr., 27:415-430.
158. Yudkoff, M., Y. Daikhin, I. Nissim, A. Lazarow, I. Nissim. (2001). Ketogenic diet, amino acid metabolism, and seizure control. J. Neurosci. Res., 66:931-940.
159. Yuen, A.W., J.W. Sander, D. Fluegel, P.N. Patsalos, G.S. Bell, T. Johnson, M.J. Koepp. (2005). Omega-3 fatty acid supplementation in patients with chronic epilepsy: a randomized trial. Epilepsy Behav., 7:253-258.
160. Zhao, Q., C.E. Stafstrom, D.D. Fu, Y. Hu, G.L. Holmes. (2004). Detrimental effects of the ketogenic diet on cognitive function in rats. Pediatr. Res., 55:498-506.